| Literature DB >> 34905794 |
Linjie Guo1, Liansong Ye1, Yilong Feng1, Johannes Bethge2, Juliana Yang3, Stefan Schreiber2, Bing Hu1.
Abstract
BACKGROUND: Endoscopic transcecal appendectomy (ETA) has been reported as a minimally invasive alternative procedure for lesions involving the appendiceal orifice. The aim of this case series study was to evaluate the feasibility, safety, and effectiveness of ETA for lesions at the appendiceal orifice.Entities:
Mesh:
Year: 2021 PMID: 34905794 PMCID: PMC9132730 DOI: 10.1055/a-1675-2625
Source DB: PubMed Journal: Endoscopy ISSN: 0013-726X Impact factor: 9.776
Fig. 1 Illustration of endoscopic transcecal appendectomy. a Near-circumferential full-thickness resection around the lesion after marking. b Introduction of the endoscope into the peritoneal cavity through the incision in order to dissect and cut off the mesoappendix and appendicular artery. c, d Snare-assisted traction of the partially dissected appendix for adequate exposure of the cutting line; a second endoscope was inserted for continuous dissection. e Closure of the defect using double endoscopic suture technique. Source: Eyeseemedical Co.,Ltd, Chengdu, China.
Fig. 2 Endoscopic images of endoscopic transcecal appendectomy. a Near-circumferential full-thickness resection around the appendiceal lesion after marking. b Dissection of the mesoappendix and appendicular artery. c Snare-assisted traction of the partially dissected appendix for adequate exposure of the cutting line. d A second endoscope was inserted for continuous dissection. e The resected lesion and appendix. f Initial closure of the defect using purse-string suture technique. g Secondary closure of the defect using endoclips. h The healing of the defect after 1 month, with residual endoloop and endoclips.
Characteristics of the patients, lesions, and outcomes (n = 13).
| Age, median (range), years | 64 (33–87) |
| Sex, n (%) | |
Male | 6 (46) |
Female | 7 (54) |
|
Comorbidity, n (%)
| 6 (46) |
|
Previous abdominal surgery, n (%)
| 3 (23) |
| Lesion type, n (%) | |
Polypoid lesion | 5 (38) |
Laterally spreading tumor | 4 (31) |
Submucosal lesion | 4 (31) |
| Lesion size, median (range), mm | 20 (8–50) |
| Histology, n (%) | |
Adenoma | 4 (31) |
Sessile serrated lesion | 2 (15) |
High grade intraepithelial neoplasia | 2 (15) |
Low grade intraepithelial neoplasia | 1 (8) |
Low grade appendiceal mucinous neoplasm (Tis) | 1 (8) |
Appendicitis with abscess or cyst | 3 (23) |
| Technical success, n (%) | 13 (100) |
| Postoperative adverse events, n (%) | 0 (0) |
| Procedure time, median (range), minutes | 167 (90–220) |
| Fasting time, median (range), days | 4 (3–13) |
| Postoperative hospital stays, median (range), days | 8 (6–18) |
| Medical cost, median (range), yuan | 37 219 (31 206–53 450) |
| Follow-up, median (range), months | 17 (1–28) |
| Recurrence, n (%) | 0 (0) |
Comorbidity including hypertension, coronary heart disease, asthma, hypothyroidism, and diabetes.
Previous surgery including surgery for rectal cancer and sigmoid colon cancer.